Status:
ACTIVE_NOT_RECRUITING
Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Schizophrenia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Schizophrenia is a serious, disabling and unfortunately common disease. Its prevalence is in the order of 0.6 to 1% in the general population, a figure that remains relatively stable in the various cu...
Eligibility Criteria
Inclusion
- French speaking
- Presenting a first or second acute psychotic episode, corresponding according to DSM 5 criteria to:
- A brief psychotic disorder
- And/or a schizophrenic disorder evolving for less than 2 years,
- Hospitalized in full time or in day care,
- Understanding and accepting the constraints of the study,
Exclusion
- Patient under guardianship
- Patient participating in another study
- Patient in hospital under restraint
Key Trial Info
Start Date :
December 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 24 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04867681
Start Date
December 8 2021
End Date
April 24 2026
Last Update
July 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06003